FLT-PET
Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CT
9
FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study
9
Evaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
9
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
13
Original Article Pre-radiotherapy assessment of non-small cell lung cancer with 18 F-FLT PET/CT or 18 F-FDG PET/CT
9
Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.
10
Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging
8
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
10
Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
8
Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging
9
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma
10
18F-FLT PET/MRI for bone marrow failure syndrome-initial experience
9
Estimation of input functions from dynamic [18F]FLT PET studies of the head and neck with correction for partial volume effects
9
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC
10
Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor
10
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma
10
Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft
8
Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis
7
Intratumoral 18F-FLT infusion in metabolic targeted radiotherapy
13
Analysis of the VEGFr1 (Flt-1) isoforms in vascular development
165